Eiskjaer H, Bagger J P, Danielsen H, Jensen J D, Jespersen B, Thomsen K, Sørensen S S, Pedersen E B
Department of Medicine and Nephrology, Skejby Hospital, Aarhus N, Denmark.
Am J Physiol. 1991 Jun;260(6 Pt 2):F883-9. doi: 10.1152/ajprenal.1991.260.6.F883.
Renal plasma flow (RPF), glomerular filtration rate (GFR), renal proximal tubular delivery of sodium and water evaluated by lithium clearance, and hormonal parameters were measured in 12 patients with congestive heart failure NYHA class II-IV before and after captopril treatment for 4 wk and in 13 healthy control subjects. RPF and GFR were significantly decreased in heart failure, whereas the filtration fraction (FF) was increased. Treatment with captopril increased RPF and decreased FF, whereas GFR was unchanged. Total and fractional urinary excretion of sodium were reduced in the patients compared with the controls, but increased after captopril. Fractional excretion of lithium was normal in heart failure and was increased by captopril. Atrial natriuretic peptide, guanosine 3',5'-cyclic monophosphate, and aldosterone in plasma were significantly elevated in heart failure and were reduced by treatment with captopril. Plasma renin activity was increased in patients, correlated inversely with RPF, and increased further after captopril treatment. It is concluded that the reduced sodium excretion in heart failure was caused by a combination of diminished glomerular filtration and enhanced tubular reabsorption beyond the proximal tubule and that treatment with captopril increased urinary sodium excretion partly due to an attenuated sodium reabsorption in the proximal tubule. The present data in patients with congestive heart failure are consistent with an increased intrarenal angiotensin II generation and an elevated plasma level of aldosterone being involved in the pathogenesis of the glomerular hemodynamic changes and the enhanced distal tubular reabsorption, respectively.
对12例纽约心脏病协会(NYHA)心功能II-IV级的充血性心力衰竭患者在卡托普利治疗4周前后以及13名健康对照者进行了肾血浆流量(RPF)、肾小球滤过率(GFR)、通过锂清除率评估的肾近端小管钠和水的输送以及激素参数的测量。心力衰竭患者的RPF和GFR显著降低,而滤过分数(FF)升高。卡托普利治疗可增加RPF并降低FF,而GFR无变化。与对照组相比,患者的钠总排泄量和分数排泄量降低,但卡托普利治疗后增加。心力衰竭患者锂的分数排泄正常,卡托普利可使其增加。心力衰竭患者血浆中的心房利钠肽、鸟苷3',5'-环磷酸和醛固酮显著升高,卡托普利治疗可使其降低。患者的血浆肾素活性增加,与RPF呈负相关,卡托普利治疗后进一步升高。结论是,心力衰竭时钠排泄减少是由于肾小球滤过减少和近端小管以外的肾小管重吸收增强共同作用所致,卡托普利治疗增加尿钠排泄部分是由于近端小管钠重吸收减弱。充血性心力衰竭患者的现有数据与肾内血管紧张素II生成增加和血浆醛固酮水平升高分别参与肾小球血流动力学变化的发病机制和远端肾小管重吸收增强一致。